Particulars |
|
|
|
Company Name
| Balaxi Pharmaceuticals Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
11.04 |
B.V. (₹) |
23.10 |
Sales(₹ Cr.) |
70.20 |
NP (₹ Cr.) |
3.69 |
NP Var (%) |
-77.00 |
Div% |
0.00 |
CPS(₹) |
0.80 |
EPS (₹) |
0.70 |
Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
151.00 |
52 Week Low |
63.00 |
Price BSE |
0.00 |
Price NSE |
65.00 |
Market Capital (₹ Cr.) |
359.46 |
P/C Ratio |
85.40 |
P/E Ratio |
97.20 |
Price Vs.BV |
2.81 |
|
Latest Quarter |
Year End |
202412 |
Sales (₹ Cr.) |
11.16 |
NP(₹ Cr.) |
1.74 |
NP Var % |
257.00 |
Trailing Twelve Months |
Year End |
202412 |
Sales |
0.00 |
OPM |
0.00 |
NP |
0.00 |
NP Var (%) |
-48.51 |
EPS |
0.53 |
PE |
122.85 |
|
|